Press Release – Population Council

Dapivirine Vaginal Ring Recommended as an HIV Prevention Option for Adolescent Girls

The European Medicines Agency expands indication of monthly dapivirine vaginal ring to include adolescent girls and women ages 16 and up, providing greater protection options for a population that remains at high risk for HIV infection.

Population Council Board of Trustees Appoints Patricia C. Vaughan and James Sailer as Co-Presidents

Investing in the Success of Adolescent Girls in Africa Requires a Targeted Approach

Johns Hopkins and Population Council Launch New Online Repository of Gender Surveys and Scales

3-Month Dapivirine Vaginal Ring for HIV Prevention Demonstrates Superior Drug Release Compared to 1-Month Ring

Ring expected to lower cost and expand choices for women globally

First-Ever Humanitarian Violence Against Children Survey (HVACS) Reveals the Toll of Violence Children Experience in Refugee Settlements in Uganda

Médunik Canada and the Population Council join in a research partnership for a potential new treatment for multiple sclerosis

If proven safe and effective throughout the remaining stages of research, segesterone acetate (SGA) could be one of the first remyelination therapies approved to treat multiple sclerosis. The project is supported in part by the National Multiple Sclerosis Society’s commercial development program, Fast Forward, LLC.